Stock Events

Stock Events

Acrivon Therapeutics (ACRV) Q2 2026 Earnings

13MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.64

-0.59

-0.53

-0.47

Details

Expected EPS

-0.524871

Actual EPS

-0.49

Surprise EPS

0.03

Surprise Percent

+6.64%

Description

Acrivon Therapeutics (ACRV) has reported earnings of -0.49 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.